minoxidil

PARIS — Consistent with what is known about minoxidil pharmacokinetics, a controlled trial found that an investigational extended-release oral formulation of minoxidil provided more favorable hair regrowth in patients with androgenetic alopecia than either immediate-release oral or topical formulations. “Comparative analysis demonstrated significant superiority for all metrics,” reported Jerry Shapiro, MD, professor of dermatology at New York University School […]

PARIS — Consistent with what is known about minoxidil pharmacokinetics, a controlled trial found that an investigational extended-release oral formulation of minoxidil provided more favorable hair regrowth in patients with androgenetic alopecia than either immediate-release oral or topical formulations. “Comparative analysis demonstrated significant superiority for all metrics,” reported Jerry Shapiro, MD, professor of dermatology at New York University School